Different edge effects of paclitaxel- and sirolimus-eluting stents on proximal and distal edges in patients with unstable angina: Serial intravascular ultrasound analysis

Chinese Medical Journal

Volumn 122, Issue 14, 2009, Pages 1603-1609

  Chen, Shao Liang ^a   Ye, Fei ^a   Zhang, Jun Jie ^a   Liu, Zhi Zhong ^a   Shan, Shou Jie ^a   Sun, Xue Wen ^b   Zhang, Ai Ping ^c   Chen, Jing Guo ^d   Xu, Ya Wei ^e   Yang, Song ^f   Chen, Feng ^g   Luo, Weng Ping ^h  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Department of Internal Medicine   (China)

^c Huainan People's Hospital   (China)

^d Chuzhou Municipal People's Hospital   (China)

^e TONGJI UNIVERSITY   (China)

^f YIXING PEOPLE S HOSPITAL   (China)

^g Wuxi No 4 People's Hospital   (China)

^h First People's Hospital of Zhangjiagang   (China)

Author keywords

Acute coronary syndrome; Drug eluting stent; Vascular remodeling

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR; HEPARIN; PACLITAXEL; RAPAMYCIN;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DIAGNOSTIC IMAGING; DRUG ELUTING STENT; DRUG IMPLANTATION; FEMALE; FOLLOW UP; HEART INJURY; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; REVASCULARIZATION; UNSTABLE ANGINA PECTORIS;

AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; CORONARY ANGIOGRAPHY; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PACLITAXEL; SIROLIMUS; TREATMENT OUTCOME;

EID: 70349558114     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.14.001     Document Type: Article

References (25)

1. Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, et al. Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003; 107; 38-42.
2. Morice MC, Serruys PW, Sousa JE, Fajadet J, Hayashi EB, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346:1771-1780.
3. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108: 788-794.
4. Abizaid A, Costa MA, Blanchard D, Albertal M, Eltchaninoff H, Guagliumie G, et al. Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients: insights from the RAVEL trial. Eur Heart J 2004; 25: 1315-1323.
5. P radioactive beta-emitting stents. Circulation 2000; 101: 2454-2457.
6. P radioactive stent. Circulation 2000; 101: 3-7.
7. Degertekin M, Serruys PW, Foley DP, Tanabe K, Regar E, Vos J, et al. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up. Circulation 2002; 106: 1610-1613.
8. Morino Y, Ako J, Sonoda S, Aoki J, Ong AT, Degertekin M. Neointimal distribution within sirolimus-eluting stents: a 3-D IVUS interim analysis from the SIRUS trial. Circulation 2002; 106 Suppl: II 391.
9. Aoki J, Abizaid AC, Serruys PW, Ong AT, Boersma E, Sousa JE, et al. Evaluation of four-year coronary artery responses after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients. J Am Coll Cardiol 2005; 46: 1670-1676.
10. Tanabe K, Serruys PW, Degertekin M, Guagliumi G, Grube E, Chan C, et al, for the TAXUS II Study Group. Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial. Circulation 2004; 109: 196-200.
11. Aoki J, Colombo A, Dudek D, Banning AP, Drzewiecki J, Zmudka A, et al Persistent remodeling and neointimal suppression two years after polymer-based, paclitaxel-eluting stent implantation. Insights from serial intravascular ultrasound analysis in the TAXUS-II study. Circulation 2005; 112: 3876-3883.
12. Jimenez-Quevedo P, Sabate M, Angiolillo DJ, Costa MA, Alfonso F, Gomez-Hospital JA, et al. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients. J Am Coll Cardiol 2006; 47: 2172-2179.
13. Lasave LI, Abizaid AAC, Costa JDR, Tanajura LF, Feres F, Abizaid AS, et al. Late vascular response at the edges of sirolimus-eluting stents in diabetic patients: An intravascular ultrasound study. Catheter Cardiovasc Interv 2007; 70: 498-503.
14. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, et al. American College of Cardiology Clinical Expert Consenus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001; 37: 1478-1492.
15. Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen WJ, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 2004; 109: 1366-1370.
16. Wardeh AJ, Albiero R, Kay IP, Knook AH, Wijns W, Kozuma K, et al. Angiographical follow-up after radioactive "Cold Ends" stent implantation: a multicenter trial. Circulation 2002; 105: 550-553.
17. Serruys P, Degertekin M, Tanabe K, Guagliumi MERG, Sebb J, Hamburger J, et al. Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial. Circulation 2004; 109: 627-633.
18. Hoffmann R, Guagliumi G, Musumeci G, Reimers B, Petronio AS, Disco C, et al. Vascular responses to sirolimus-eluting stents delivered with a non-aggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials. Catheter Cardiovasc Interv 2005; 66: 499-506.
19. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, et al. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation 1996; 94: 1247-1254.
20. Weissman NJ, Wilenski RL, Tanguay JF, Bartorelli AL, Moses J, Williams DO, et al. Extent and distribution of in-stent intimal hyperplasia and edge effect in a non-radiation stent population. Am J Cardiol 2001; 88: 248-252.
21. Mudra H, Regar E, Klauss V, Werner F, Henneke KH, Sbarouni E, et al. Serial follow-up after optimized ultrasound-guided deployment of Palmaz-Schatz stents: in-stent neointimal proliferation without significant reference segment responses. Circulation 1997; 95: 363-370.
22. Kimura M, Carlier SG, Mintz GS, Fujii K, Costa JR, Sano JK, et al. Stent edge vascular responses after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. Circulation 2005; 112: II 769.
23. Hong MK, Mintz GS, Lee CW, Suh J, Kim JH, Park DW, et al. Comparison of virtual histology to intravascular ultrasound of culprit coronary lesions in acute coronary syndrome and target coronary lesions in stable angina pectoris. Am J Cardiol 2007; 100: 953-959.
24. Dibra A, Kastrati A, Mehilli J, Pache J, Schuhlen H, Von Beckerath N, et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005; 353: 663-670.
25. Morice MC, Colombo A, Meier B, Serruys P, Tamburino C, Guagliumi G, et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA 2006; 295: 895-904.